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Abstract
Introduction: Neuronal morphogenesis is governed mainly by two intercon-
nected processes, cytoskeletal reorganization, and signal transduction. The
actin-binding molecule WIP (Wiskott-Aldrich syndrome protein [WASP]-inter-
acting protein) was identified as a negative regulator of neuritogenesis.
Although WIP controls activity of the actin-nucleation-promoting factor neural
WASP (N-WASP) during neuritic differentiation, its implication in signal trans-
duction remains unknown. Methods: Using primary neurons from WIP-defi-
cient and wild-type mice we did an immunofluorescence, morphometric, and
biochemical analysis of the signaling modified by WIP deficiency. Results: Here,
we describe the WIP contribution to the regulation of neuritic elaboration and
ramification through modification in phosphorylation levels of several kinases
that participate in the mammalian target of rapamycin complex 1 (mTORC1)-
p70S6K (phosphoprotein 70 ribosomal protein S6 kinase, S6K) intracellular sig-
naling pathway. WIP deficiency induces an increase in the number of neuritic
bifurcations and filopodial protrusions in primary embryonic neurons. This
phenotype is not due to modifications in the activity of the phosphoinositide 3
kinase (PI3K)-Akt pathway, but to reduced phosphorylation of the S6K residues
Ser411 and Thr389. The resulting decrease in kinase activity leads to reduced S6
phosphorylation in the absence of WIP. Incubation of control neurons with
pharmacological inhibitors of mTORC1 or Abl, two S6K regulators, conferred a
morphology resembling that of WIP-deficient neurons. Moreover, the preferen-
tial co-distribution of phospho-S6K with polymerized actin is altered in WIP-
deficient neurons. Conclusion: These experiments identify WIP as a member of
a signaling cascade comprised of Abl family kinases, mTORC1 and S6K, which
regulates neuron development and specifically, neuritic branching and complex-
ity. Thus, we postulated a new role for WIP protein.
ª 2015 The Authors. Brain and Behavior published by Wiley Periodicals, Inc.
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Introduction
The precise regulation of neuron morphogenesis is a cen-
tral event in the development of the functional properties
of neurons, and thus forms the cellular basis of nervous
system function (Kollins and Davenport 2005). Given the
complexity of the neuronal network in vivo, cell culture
of isolated neurons is used as a model to study the
molecular processes that control this sophisticated mor-
phogenesis (Dotti et al. 1988). In this cell system, early
postmitotic rounded neurons initiate protrusion of three
to five minor neurites; after several hours, one becomes
polarized and forms a single axon, whereas the remaining
neurites differentiate to dendrites that branch during mat-
uration for correct connectivity and function (da Silva
and Dotti 2002). The molecular mechanisms that underlie
this morphogenetic process, and specifically the spatial
and temporal molecular events that orchestrate the cyto-
skeletal and signaling changes involved, are not fully
understood.
From the onset, extension of the initial neurites is reg-
ulated by the cytoskeleton; microtubules (MT) and actin
microfilaments (MF) have a key function in neuritic initi-
ation and in the maintenance of neuron morphology and
polarity (Black and Baas 1989; Baas 1997; Yin et al. 2008;
Arnold 2009). These two cytoskeletal elements have some
opposing functions: general MT depolymerization with
drugs blocks initial neuritic elongation and growth,
whereas MF depolymerization leads to generation of mul-
tiple axons (Bradke and Dotti 1999). These data and
other reports led to the proposal that MF and MT control
neuritic extension, complexity, morphological properties,
and subsequent polarization.
In neurons, as in many other cell types, MF dynamics
relies mostly on F-actin polymerization controlled by the
conserved Arp2/3 (actin-related proteins) complex and by
nucleation-promoting factors such as cortactin and neu-
ral-Wiskott Aldrich syndrome protein (N-WASP) (Pollard
et al. 2000; Hering and Sheng 2003; Racz and Weinberg
2004; Tsuchiya et al. 2006; Wegner et al. 2008; Padrick
and Rosen 2010). There is, however, much less informa-
tion about the role of the cortactin- and N-WASP-bind-
ing protein WIP (WASP-interacting protein) in neurons.
In other cell types, WIP binds to actin as well as to N-
WASP and cortactin, which regulate actin nucleation
activity at specific sites (Paunola et al. 2002; Anton et al.
2007). We reported WIP expression in adult mouse brain
and cultured embryonic cortical and hippocampal neu-
rons; WIP deficiency promotes premature neuritic initia-
tion and dendritic maturation in primary murine neurons
without affecting axon complexity or number (Franco
et al. 2012). Our results, based on the use of the pharma-
cological inhibitor wiskostatin, indicate that WIP controls
N-WASP activity in embryonic murine neurons. By con-
trolling activity of an actin-binding protein and by exten-
sion, actin dynamics, WIP thus acts as a negative
regulator of soma size as well as of neuritic initiation and
maturation in vitro and in vivo.
A number of extracellular signals regulate neuron mor-
phogenesis through various pathways. The IGFR1 (insu-
lin-like growth factor receptor-1)-PI3K-Akt pathway
controls neuritic outgrowth and promotes axonal polarity
and dendritic branching (Sosa et al. 2006). Some elements
in this pathway, such as Par3/Par6/aPKC, GSK3 (glycogen
synthase kinase 3) or the multiprotein complex mamma-
lian target of rapamycin complex 1 (mTORC1) are impli-
cated directly in the generation and/or maintenance of
neuronal polarity and complexity (Jaworski et al. 2005; Ji-
ang et al. 2005; Gartner et al. 2006; Jaworski and Sheng
2006). Mammalian Target of Rapamycin (mTORC1and
mTORC2) are central mediators of cell growth and of
increase in cell mass and size (Laplante and Sabatini
2009). Both mTORC1 and S6K regulate soma size and
dendritic arborization in neurons (Kwon et al. 2003). S6K
activation is controlled by stepwise phosphorylation of
several Serine/Threonine residues located within the au-
toinhibitory domain, including Ser411 (Dufner and Tho-
mas 1999). The phosphorylation at Ser411 is required for
the subsequent phosphorylation of Thr389 site which may
allow the full activation of this kinase (Hou et al. 2007).
Another signaling family, the Abelson murine leukemia
tyrosine kinases (Abl) which consists of Abl and Abl2
(also called Arg), modulate dendrite formation in the
developing nervous system through negative regulation of
the Enabled protein (de Curtis 2007) or stimulation of
Robo/Slit signaling (Bashaw et al. 2000; Wills et al. 2002).
Abl-mediated phosphorylation also controls the stability
of dendrite branching in mice, as reduction of kinase lev-
els is accompanied by decreased branching in early adult-
hood (Moresco et al. 2005).
S6K binds F-actin directly; this binding is dependent
on the S6K phosphorylation level, which promotes actin
filament crosslinking and stabilization (Moresco et al.
2005; Ip et al. 2011). The mTORC1-S6K pathway is
involved in actin cytoskeleton reorganization, stimulated
by growth factors that induce phosphorylation of focal
adhesion proteins (Liu et al. 2008) and promote RhoA
expression and activity (Liu et al. 2010). RhoA activity is
also modulated by Abl family kinases (Bradley and Kol-
eske 2009).
The WIP contribution to cell signaling is scarcely stud-
ied in fibroblasts, lymphocytes, and mast cells (Anton
et al. 2007; Noy et al. 2012) and, to our knowledge, has
not been addressed in neuron signaling. Here, we ana-
lyzed how WIP controls posttranslational modifications
that regulate early morphogenesis of primary neurons.
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Our data indicate that WIP not only has a cytoskeleton-
dependent role, but also governs signaling through
mTORC1- and Abl family kinases-dependent modulation
of the S6K pathway, which controls neuritic extension
and branching.
Methods
Mice
WT and WIP/ SV129/BL6 mice (Anton et al. 2002)
were housed in specific pathogen-free conditions at the
animal facility of the Centro de Biologıa Molecular Severo
Ochoa, Madrid, Spain. The colony was maintained by
continuous mating of heterozygous females with heterozy-
gous males for more than 25 generations. To obtain con-
trol or WIP/ embryos, we mated homozygous control
or WIP/ pairs of mice. All cell-related quantification
was conducted in a genotype-blind manner. Mouse han-
dling and all manipulations were carried out in accor-
dance with national and European Community
guidelines, and were reviewed and approved by the insti-
tutional Animal Care and Use Committee.
Cell culture and immunofluorescence
microscopy
Primary hippocampal or cortical cultures were prepared
and processed for immunofluorescence as described
(Franco et al. 2012). Briefly, the hippocampus and cortex
were obtained from mouse embryos on embryonic day
(E)17–18 and rinsed three times in washing solution:
Ca2+/Mg2+-free HBSS (Hank’s balanced salt solution).
The hippocampus was digested with 0.25% trypsin
(Sigma, St. Louis, MO) and the cortex with 0.25% trypsin
plus 1 mg/mL DNase (Roche Diagnostics, Indianapolis,
IN), both for 15 min in the washing solution. Tissue was
then washed three times in washing solution and dissoci-
ated with a fire-polished Pasteur pipette. Cells were
counted, resuspended in plating medium (MEM, 10%
horse serum, 0.6% glucose), and plated at a density of
6 9 103 cells/cm2 (hippocampal neurons) or 1.5 9 105
cells/cm2 (cortical neurons) on poly-L-lysine (PLL;
Sigma)-coated coverslips (1 mg/mL). In some experi-
ments, neurons were allowed to adhere to the substrate
(1 h) and then incubated with 20 nM Rapamycin (Cal-
biochem, Darmstad. Germany) or with 1, 3 or 10 lM I-
matinib mesylate (Selleck, Houston, TX) both in dimethyl
sulfoxide (DMSO). The doses were selected based on
published reports using immature primary neuronal cul-
tures (Woodring et al. 2002; Jones et al. 2004; Jaworski
et al. 2005; Choi et al. 2008). After 3 h, plating medium
was replaced with Neurobasal Medium supplemented
with B27 and Glutamax-I (all from Gibco, Carlsbad, CA).
After 24 h of in vitro culture hippocampal cells were fixed
in 4% paraformaldehyde in Ca2+Mg2+-containing PBS,
pH 7.4 (20 min, room temperature), then permeabilized
with 0.1% Triton X-100 and labeled with monoclonal
antibody (mAb) to tyrosinated a-tubulin (TT; 1/400;
T9028), TRITC-phalloidin (1/500; P1951; both from
Sigma), and polyclonal anti-p70S6K-pThr389 (1/60; 9205)
or -p70S6K antibody (1/60; 9202; both from Cell Signal-
ing Tech, Danvers, MA). The anti-phosphorylated epitope
antibody was incubated in Dako Antibody Diluent with
background reducing components (Dako, Glostrup, Den-
mark) and 5 mM NaF.
Images were recorded digitally on a LSM510 Meta con-
focal microscope coupled to an inverted Axiovert 200
microscope (both from Zeiss, Oberkochen, Germany)
equipped with a CCD camera, and processed with LSM
Image Browser software and Adobe Photoshop. Cells
showing obvious signs of toxicity, such as neuritic frag-
mentation/blebbing or vacuoles in the cell body, were
excluded from analysis.
Morphometric analysis
Morphometric measurements of cultured hippocampal
neurons were performed with Image J Software (National
Institute of Health [NIH], Bethesda, MD). Each experi-
ment was repeated at least three times on independent
preparations. Actin and tubulin in neurons were labeled
and tubulin distribution was traced for morphometric
analysis. Sholl analysis was performed for each traced
neuron by automatically calculating the number of neu-
ritic intersections at 20 lm intervals starting from the
soma. The total neuritic length and the number of neu-
ritic branch points were counted after 24 h in culture,
also calculated as an index of dendritic complexity.
Fluorescence intensity measurement and
multiple dye localization
Fluorescence was measured after applying an inclusive
threshold and manually setting threshold limits to prevent
pixels from extracellular regions being considered posi-
tive. S6K fluorescence intensity per neuron was measured
as integrated fluorescence intensity. S6K-pThr389, S6K or
F-actin occupied area per growth cone were determined
as percentage of thresholded area per channel over the
total growth cone area. For quantitative area measure-
ment of the overlapping region in maximum projection
from images of confocal stacks of Alexa488-anti-rabbit
S6K-pThr389 (green) and TRITC-phalloidin (red) staining,
we first established an intensity threshold for each fluores-
cent channel. We selected the growth cone F-actin-rich
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area as the one with greater fluorescence intensity and
greater pixel density for phalloidin positive signal. The
growth cone area comprising the rest of the phalloidin-
associated signal was considered F-actin sparse. Regarding
F-actin neuritic patches, we first established an intensity
threshold for the greater pixel density for phalloidin posi-
tive signal in such a way that discrete F-actin patches
could be clearly differentiated from the rest of the neuritic
shaft. Then these thresholded areas were selected as F-
actin patches. The adjacent regions with lower signal
intensity, F-actin sparse, were considered as the sides of
F-actin patches and later averaged. The overlap area, that
is, the region including integrated intensity (the sum of
all intensity values for all pixels in the region) of the
green on the red dye, was measured with the Measure
Colocalization tool in the selected regions. All measure-
ments were made using Metamorph 7.5.2.0 software
(Molecular Devices, Sunnyvale, CA).
Cell lysates and Western blot
For biochemical analysis, postmitotic cortical neurons were
plated on 1 mg/mL PLL-coated dishes; all times are given
as hours post seeding. Neuronal extracts were obtained in
lysis buffer (20 mM HEPES pH 7.4, 100 mM NaCl, 5 mM
EDTA, 1% Triton X-100, 100 mM NaF, 1 mM Na3VO4,
complete protease inhibitor cocktail (Roche Diagnostics)
and 1 mM okadaic acid) and resolved by 8 or 10% SDS-
PAGE after calculating protein concentration by Bradford
analysis (BioRad, Hercules, CA). Proteins were transferred
to nitrocellulose filters, blocked and incubated with poly-
clonal antibodies anti-Akt pThr308 (1/500; 9275), -Akt
pSer473 (1/500; 9271), -Akt (1/1000; 9272), -GSK3 pSer21,9
a,b (1/1000; 9331), S6K pThr389 (1/500; 9205), S6K (1/
1000; 9202), -S6 ribosomal protein pSer235/236 (1/500;
2211), -p44/42 MAP kinase (1/1000; 9102), -p38MAPK (1/
1000; 9212) or -SAPK/JNK (1/1000; 9252; all from Cell Sig-
naling Tech), S6K pSer411 (1/1000; ab47372; Abcam, Cam-
bridge, UK), -PDK1 (1 lg/mL; kindly provided by Prof.
Dario Alessi, MCR, Dundee, UK), or mAb anti-GSK3 a, b
(1/1000; 44-610, Biosource, Paisley, UK), -GAPDH (1/
2500; OBT 1636; AbD Serotec, Oxford, UK), -a-tubulin (1/
2500; T9026, Sigma), -ERK pThr202/Tyr204 (1/1000; 4377), -
p38MAPK pThr180/Tyr182 (1/1000; 9215) or -JNK pThr183/
Tyr185 (1/1000; 4668; all three from Cell Signaling Tech).
All anti-phosphorylated epitope antibodies were incubated
in TBS-Tween with nonfat dry milk and 5 mM NaF.
After incubation with goat anti-mouse IgG-HRP (1/
5000; sc-2005), goat anti-rabbit IgG-HRP (1/5000; sc-
2004; both from Santa Cruz Biotech, Santa Cruz, CA) or
rabbit anti-goat Ig-HRP (1/2000; P 0449; Dako Cytoma-
tion, Glostrup, Denmark), binding was visualized by ECL
(Amersham Biosciences, Piscataway, NJ).
Quantification of phosphorylation
Densitometric quantification of bands was performed using
ImageJ. Data from independent experiments were first nor-
malized to the band of greatest intensity using the same
antibody and in the same membrane; the signal was then
normalized relative to that of the total protein control.
Statistical analysis
Data are presented as mean  standard error of the mean
(SEM). Differences between experimental groups were
evaluated for significance using Student’s t-test or two-
way ANOVA. For all analyses, a minimum value of
P < 0.05 was considered significant. All statistical analyses
were performed using GraphPad Prism version 5.0.
(GraphPad Software, Inc., La Jolla, CA).
Results
Numbers of neuritic bifurcations and
filopodial protrusions increase in the
absence of WIP
WIP is a negative regulator of early neuritogenesis that
controls primary neuritic outgrowth and number
(Franco et al. 2012). To determine in detail how WIP
affects to this process, we carried out morphometric
analyses of primary neuron cultures from control and
WIP-deficient (WIP/) mice. Cells from trypsin-dissoci-
ated embryonic (E17-18) hippocampus were seeded onto
PLL-coated coverslips, allowed to differentiate in vitro,
fixed, then stained with anti-tyrosinated a-tubulin (TT)
to label dynamic MT and with TRITC-phalloidin to
label actin MF (see Methods). After 24 h differentiation,
neurons reached a morphological stage defined by the
presence of tubulin-rich neurites ending in F-actin-rich
growth cones (Fig. 1A and B). Morphometric analysis
showed that in the absence of WIP, average total neu-
ritic length (tubulin-positive extensions) per cell was
almost twice that of control neurons (641.8  84.9 lm
vs. 338.9  39.2 lm; P = 0.0009; Fig. 1C). WIP/ neu-
rons also showed a significant increase in the average
number of neuritic branches or bifurcations per neuron
(5.4  1.2 vs. 2.5  0.4; n = 30; P = 0.001; Fig. 1D).
Increased complexity was evident when the pattern of
branching of the neuritic tree was analyzed quantitatively
using Sholl analysis to measure the number of neurites
crossing circles at various radial distances from the soma
(Sholl 1953). The number of crossings was significantly
higher in WIP/ neurons when compared with WT
neurons at 24 h (Fig. 1E). We concluded that the
increased total neuritic length observed in the absence of
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WIP was due to the higher level of neuritic branching,
as the average length of each neuritic branch was not
modified in WIP/ neurons (Fig. S1). Therefore, here-
after we analyzed the number of bifurcations per neuron
as a measure of neuritic tree complexity. Neuritic
sprouting starts at actin-rich filopodial protrusions (Dent
et al. 2007). To test whether the WIP contribution to
neuron complexity was linked to this very early event,
we quantified the number of neuritic filopodia and F-
actin patches (transient accumulations of F-actin within
the neuritic shaft which serve as precursors for neuritic
filopodia [Loudon et al. 2006; Hu et al. 2012; ]) per
length unit in WT and WIP/ neurons. WIP/ neu-
rons had almost twice as many neuritic filopodia as con-
trols (Fig. 1F and G), whereas the number of neuritic
actin patches per length unit decreased significantly in
the absence of WIP (Fig. 1H). In addition to confirming
our previous report, which showed that neuritogenic
activity is accelerated and final complexity enhanced in
one-day-cultured WIP/ neurons; these results suggest
that early events such as filopodium initiation underlie
these processes.
(A)
(C) (D) (E)
(F) (G) (H)
(B)
Figure 1. WIP deficiency increases neuritic
branching and filopodium formation in
dissociated hippocampal murine neurons.
(A) Representative confocal images of
dissociated embryonic WT and WIP/
hippocampal neurons (E18) fixed 24 h post
plating and stained for F-actin (TRITC-
phalloidin, red) and MT (Alexa488-anti-
tyrosinated tubulin (TT), green). WIP/
neuron morphology was more complex
than that of WT neurons. Scale bar,
10 lm. (B) High magnification images of
the insets in A. Scale bar, 10 lm. (C)
Average total neuritic length increased in
24-h-cultured WIP/ compared to WT
hippocampal neurons. The morphology of
30 neurons per genotype was
characterized. (D) Average number of
bifurcations per neuron increased in WIP/
compared to WT neurons. (E) Sholl
analysis of traced WT and WIP/ neurons
showing higher number of crossings in
WIP/ neurons. n = 17 neurons analyzed
per experimental group, from three
independent experiments. ***P < 0.001
(Two-way ANOVA). (F) Representative
confocal images of WT and WIP/
neurons obtained and stained as in (A).
Right images show higher magnification of
the boxed area in left images (scale bar,
10 lm for both). Neuritic filopodia
(arrows), neuritic actin patches (asterisks).
(G,H) Quantification of neuritic filopodia
and actin patches per 10 lm in WT and
WIP/ neurons. Data for 50 neurons per
group in three independent experiments.
Student’s t-test; ***P < 0.001.
ª 2015 The Authors. Brain and Behavior published by Wiley Periodicals, Inc. Brain and Behavior, doi: 10.1002/brb3.359 (5 of 18)
A. Franco-Villanueva et al. WIP Modulates S6K Activity in Neuron
Akt and GSK3 activities are not
substantially modified in WIP/ neurons
Several signaling pathways govern neuron morphogenesis
and polarity, including the crucial IGFR1-PI3K axis (Sosa
et al. 2006). To evaluate WIP influence on signaling path-
ways that control neuritic elaboration, we analyzed pro-
tein levels and/or the phosphorylation state of the PI3K
downstream kinases, such as PDK1 (phosphoinositide-
dependent kinase-1) or Akt.
Akt activity is inferred from phosphorylation levels of
its amino acids Thr308 and Ser473 (Vanhaesebroeck and
Alessi 2000), and can also be deduced from the phos-
phorylation of one of its common substrates, GSK3.
Consequently, the phosphorylation level of GSK3-a Ser21
and GSK3-b Ser9 correlates with Akt activity (Cohen
and Frame 2001) and PDK1 activity may be deduced
from Akt-Thr308 phosphorylation levels (Alessi et al.
1996).
To study Akt activity during neuron development, we
allowed cortical neurons from age-matched WIP/ and
WT embryos to differentiate in vitro for 1–48 h after
plating. Cell extracts were prepared and western blot
(WB) performed using phosphorylation-specific antibod-
ies to Akt-Thr308 and -Ser473, with anti-Akt antibody as
protein loading control.
In WT neurons, kinetics from the two phospho-epi-
topes was similar; both Akt-pThr308 and Akt-pSer473 im-
munoreactivities increased progressively over a 48-h
period (Fig. 2A–D). We found no significant differences
in Akt-pThr308 or Akt-pSer473 phosphorylation values
between genotypes in the overall time-course determined
(Fig. 2A–D). To confirm these results, we also analyzed
levels of PDK1, the enzyme responsible for Akt-Thr308
phosphorylation, and found no major changes in the
amount of total kinase after 24 h of neuron culture, in
accordance with data for Akt-pThr308 (Fig. S2).
To confirm that the minor variations in Akt phosphor-
ylation did not influenced Akt kinase activity, we mea-
sured phosphorylation of the Akt substrate GSK3. As
expected WT neurons showed a slight increase in GSK3-
Ser21/9 phosphorylation, evident at 24 and 48 h post plat-
ing. Specifically, the increase in GSK3-Ser21/9 phosphory-
lation observed at 24h post plating is concurrent with the
time described for axon initiation in vitro, an event
dependent on GSK3 activity (Jiang et al. 2005; Garrido
et al. 2007; Hur and Zhou 2010). As anticipated from
previous results, we found no substantial differences in
GSK3-pSer21/9 levels between WIP/ and WT primary
neuron extracts (Fig. 2E–F). The results indicate that, in
murine primary neurons, WIP does not contribute
notably to signaling pathways involving Akt-GSK3
phosphorylation and activation.
S6K activity is reduced in WIP/ neurons
RheB/mTORC1/S6K is another major PI3K pathway com-
ponent that regulates neuritic extension and neuron
polarity (Jaworski and Sheng 2006; Morita and Sobue
2009). In addition to its role in neuritogenesis, mTORC1
is a general regulator of protein synthesis, cell growth and
size in many cell types (Laplante and Sabatini 2009). To
infer mTORC1/S6K pathway activity during in vitro neu-
ronal development, we cultured cortical neurons from
WIP/ and WT mice as above and determined the S6K
phosphorylation level.
The S6K-Thr389 phosphorylation level is associated with
mTORC-1 activity (reviewed in Ekim et al. 2011; Zoncu
et al. 2011) in contrast to S6K-Ser411 phosphorylation
which has been reported as mTORC1 independent
(Schalm et al. 2005; Hou et al. 2007).
Soluble cell extracts were obtained from primary neu-
rons plated from time 0 to 48 h, and WB performed
using phosphorylation-specific S6K-Ser411 and -Thr389
antibodies, and anti-S6K antibody as loading control. A
variety of reporters can be used to quantify activity in this
pathway; Abl-mediated Cdk5/p35 activity, detected from
the S6K-pSer411 immunoreactivity (Hou et al. 2007), was
significantly different between WT and WIP/ neurons
(Fig. 3A and B). The phosphorylation level of S6K-Thr389
and/or that of S6, its main substrate, are commonly mea-
sured to determine final activity (Ruvinsky et al. 2005;
Ekim et al. 2011; Zoncu et al. 2011). We observed that
mTORC1 activity increased at 1 h post plating in control
neurons, as inferred from the S6K-pThr389 level (Ekim
et al. 2011), whereas S6K-Thr389 phosphorylation was sig-
nificantly lower in WIP/ neurons up to 24 h post plat-
ing (Fig. 3C and D).
To determine whether these differences effectively influ-
ence S6K activity, we used a specific antibody to test
phosphorylation at residues Ser235/236 of S6, the main S6K
substrate (Meyuhas 2008). The temporal pattern of S6
phosphorylation at Ser235/236 slowly decrease up to 24 h
post platting being more pronounced and statistically
lower in WIP/ neurons compared to the WT kinetics
(Fig. 3E and F).
These data correlated with the lower activity inferred
from S6K-Ser411 and -Thr389 phosphorylation (Fig. 3B
and D) and confirm reduced S6K activity in WIP/ neu-
rons.
The Abl family kinases inhibitor imatinib
reduces S6K-Ser411 phosphorylation and
increases neuritic complexity in WT neurons
The S6K-Ser411 phosphorylation level is associated with
Abl-mediated Cdk5/p35 activity (Kumar et al. 2000; Hou
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et al. 2007). To test whether reduced Abl activity is
responsible for the differences observed between WIP/
and WT neurons, we cultured primary neurons from
both genotypes alone, with the Abl inhibitor imatinib, or
with DMSO. After 24 h, soluble cell extracts were
obtained and WB performed using anti-S6K-pSer411 anti-
bodies to confirm that the pharmacological treatment was
effective. Imatinib addition reduced S6K-pSer411 immu-
noreactivity in WIP/ and WT neurons without affect-
ing S6K-pThr389 levels (Fig. S3). Abl inhibition in WT
neurons by 3 lM imatinib treatment led to S6K-pSer411
phosphorylation levels resembling those of control
DMSO-treated WIP/ neurons (Fig. S3B), suggesting
that WIP deficiency modifies Abl activity during neuronal
differentiation. The morphological effects of Abl inhibi-
tion were confirmed in imaging experiments; WIP/ or
WT neurons were incubated with imatinib, fixed, and
stained with anti-TT antibody. Morphology analysis of
number of bifurcations per neuron showed that neuronal
complexity increased in imatinib-treated WT cells, mim-
icking that of WIP/ neurons (Fig. 4A and B), whereas
Abl inhibition reduced the number of bifurcations in
WIP/ neurons. Sholl analysis supports these results
(Fig. 4C). These data show the requirement of Abl family
kinases activity for S6K phosphorylation over early neu-
ron development in vitro and suggest that WIP might
(A) (B)
(C) (D)
(E) (F)
Figure 2. Akt and GSK3 phosphorylation are not modified in WIP/ neurons. Soluble extracts were obtained from murine primary cortical
neurons from WT or WIP/ embryos and maintained in suspension (0) or cultured at high density for 1, 2, 3, 24, or 48 h on PLL-coated plates.
Proteins analyzed in WB (25 lg/lane) were probed with antibodies to phosphoepitopes (A,B) Akt-pThr308, (C,D) Akt-pSer473 or (E,F) GSK3-pSer21/9.
Equivalent protein loading was confirmed using anti-Akt or -GSK3 antibodies. Images show one representative experiment. Data show as
mean  SEM; from four independent experiments; ns, not significant (two-way ANOVA analysis).
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negatively regulate neuronal maturation modulating S6K
activation by Abl.
The mTORC1 inhibitor rapamycin modifies
neuritic branching
As previously mentioned, S6K-Thr389 is associated with
mTORC-1 activity, whereas S6K-Ser411 appears to be
mTORC1-independent, as it is rapamycin-insensitive
(Schalm et al. 2005; Hou et al. 2007).
To determine whether mTORC1 activity is responsible
for the morphological and biochemical differences
observed in WIP/ neurons, we cultured control and
WIP/ cells with rapamycin, with the DMSO vehicle, or
untreated. At different times postplating (0, 3, and 24 h),
soluble cell extracts were obtained from WIP/ and WT
neurons and WB performed using antibodies specific for
S6K-pThr389, S6K-pSer411, and S6-pSer235/236 to verify
that rapamycin was inhibiting mTORC1 activity. As
expected, rapamycin slightly block S6K-Ser411 phosphory-
lation (Fig. S4A and B), and as predicted, strongly
blocked S6K-Thr389 and S6-Ser235/236 phosphorylation in
both neuronal genotypes at 24 h (Fig. S4A, C and D).
In analogous experiments, rapamycin-treated WIP/
and WT neurons were fixed and stained with TRITC-
phalloidin and anti-TT antibody (Fig. 5A). In parallel
with reduced S6K-pThr389 levels, the number of bifurca-
tions per neuron and neuritic complexity increased in ra-
pamycin-treated WT neurons (Fig. 5A–C). Rapamycin
treatment of WT neurons mimicked and, indeed, magni-
fied the effect of WIP deficiency by increasing the number
of bifurcations per neuron compared to DMSO-treated
(A) (B)
(C) (D)
(E) (F)
Figure 3. Phosphorylation of S6K and of S6 is reduced in WIP/ cells during neuron differentiation. Soluble extracts were obtained from murine
primary cortical neurons from WT or WIP/ embryos and maintained in suspension or cultured as in Fig. 2. Proteins were analyzed in WB (25 lg/
lane) using antibodies to phosphoepitopes (A,B) S6K-pSer411, (C,D) S6K-pThr389, or (E,F) S6-pSer235/236. Equivalent protein loading was confirmed
with anti-S6K or -GAPDH antibodies. (B,D,F) Densitometric analysis of the relative amount of each phosphoprotein relative to total protein.
Images show a representative experiment. Data show as mean  SEM; from four independent experiments. Black asterisks over the means refer
to the statistical significance of mean differences between the two genotypes for each discrete time point. Gray asterisks placed in the lower
right corner of the graphs refer to the statistical significance of differences between the distributions. (B) *P < 0.05 (two-way ANOVA), (D)
*P < 0.05; **P < 0.01 (Student’s t-test); ***P < 0.001 (two-way ANOVA), (F) **P < 0.01 (two-way ANOVA).
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WIP/ neurons. The increase in soma area associated
with rapamycin administration in WT neurons confirms
the effect on soma area described for WIP deficiency
(Franco et al. 2012) (Fig. S5A). The phenotypes induced
by mTORC1 inhibition in controls resembled those of
WIP/ neurons (Fig. 5A–C), suggesting that WIP con-
tributes to mTORC1 activity during primary murine neu-
ron differentiation.
In contrast, rapamycin-treated WIP/ neurons showed
reduced number of bifurcations compared to DMSO-trea-
ted WIP/ neurons and rapamycin-treated WT cells
(Fig. 5A and B). Our data show that rapamycin induces
an increase in the WT neuronal complexity, apparently
contradicting published data. Rapamycin has been previ-
ously used to define the mTORC1 contribution to neuro-
nal polarization in neurons cultured longer than 3 days
(Jaworski et al. 2005; Choi et al. 2008; Li et al. 2008).
Thus, we carried out a control experiment to confirm this
published data. And certainly (in our experiments) rapa-
mycin treatment of WT neurons for 3 days significantly
reduced axonal length (Fig. S5B), supporting the previous
reports.
Considering that early neuritogenic events such as fi-
lopodium initiation was increased in WIP/ neurons, we
quantified the density of neuritic filopodia and F-actin
patches in rapamycin-treated WT and WIP/ neurons to
determine whether mTORC1 activity is also responsible
for the differences in induction of actin-based membrane
protrusions observed in WIP/ neurons. Cells were fixed
at 24 h post plating and stained with TRITC-phalloidin
and anti-TT antibody. Vehicle-treated WIP/ neurons
had almost thrice as many neuritic filopodia as controls
(Fig. 5D), whereas the density of neuritic F-actin patches
was decreased compared to control neurons (Fig. 5D).
Rapamycin treatment of WT neurons increased the
density of neuritic filopodia, whereas it was reduced in
(A) (B)
(C)
Figure 4. Imatinib inhibition of Abl kinases increases neuritic bifurcations in WT cells, mimicking WIP deficiency. (A) Representative images of
dissociated WT and WIP/ hippocampal neurons incubated for 24 h with DMSO or 3 lM imatinib, fixed, and stained with anti-TT mAb. Scale
bar, 50 lm. (B) Quantification of experiments in (A). Note the larger number of bifurcations in WIP/ neurons in DMSO, which is equivalent to
that of WT neurons in 3 lM imatinib. n = 150 neurons analyzed per experimental group, from three independent experiments; ns, not
significant; *P < 0.05; ***P < 0.001 (Student’s t-test). (C) Sholl analysis of traced neurons, after imatinib treatment of WT and WIP/ cells. The
quantification shows higher number of crossings in WIP/ neurons compared to WT cells before treatment. After treatment with imatinib 3 lM,
WT neurons show increased branching compared to DMSO-treated WT neurons. n = 30 neurons analyzed per experimental group, from three
independent experiments. ***P < 0.001 (WIP/ neurons compared to WT cells before treatment); ns, not significant (imatinib-treated WT
neurons compared to DMSO-treated WIP/ cells) (Two-way ANOVA).
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rapamycin-treated WIP/ neurons. However, the density
of F-actin patches was not affected by rapamycin treat-
ment in either genotype. In addition to being consistent
with the effect of rapamycin on neuritic branching and
complexity, these results suggest that WIP participates in
mTORC1 activity over early protrusive events but not in
the formation of its precursors, F-actin patches.
S6K-pThr389 is lower in the cell body and
neuritic shaft in WIP/ than in WT neurons
S6K-pThr389 is found in dendrites and soma of mature
neurons (Cammalleri et al. 2003). To determine if its
localization is similar in immature neurons, and
whether the biochemical differences observed are region
(A)
(D)
(B)
(C)
Figure 5. Rapacymin inhibition of mTOR in WT neurons phenotypically mimics WIP/ neuritic complexity. Primary neurons from WT or WIP/
murine embryos were dissociated and cultured with vehicle (DMSO), or with rapamycin (20 nM). (A) Representative images of rapamycin-treated
neurons fixed at 24 h postplating and co-labeled with TRITC-phalloidin (F-actin, red) and Alexa488-anti- a-tyrosinated tubulin (TT, green). Scale
bar, 50 lm. (B) Average number of bifurcations per neuron, alone or rapamycin-treated. n = 100 neurons analyzed per experimental group from
two independent experiments. **P < 0.01; ***P < 0.001 (Student’s t-test). (C) Sholl analysis of traced neurons, after indicated treatments of WT
and WIP/ cells. The quantification shows higher number of crossings in WIP/ neurons compared to WT cells before treatment. After
rapamycin treatment, WT neurons show similar number of crossings that WIP/ neurons before treatment. n = 30 neurons analyzed per
experimental group from three independent experiments. ***P < 0.001 (WIP/ neurons compared to WT cells before treatment); ns, not
significant (rapamycin-treated WT neurons compared to DMSO-treated WIP/ cells) (Two-way ANOVA). (D) Quantification of neuritic filopodia
and F-actin patches per 10 lm in WT and WIP/ neurons. Data for 350 filopodia and 355 F-actin patches, n = 40 neurons analyzed per
experimental group from three independent experiments. *P < 0.05, ***P < 0.001; ns, not significant (Student’s t-test).
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specific, we cultured primary hippocampal neurons
from WT and WIP/ mice for 24 h, followed by fix-
ing and staining with TRITC-phalloidin and anti-S6K
and -S6K-pThr389 antibodies. In WT neurons, both
total S6K and S6K-pThr389 occupied the soma and neu-
rites, including tips of all extensions; total S6K also
showed more apparent perinuclear staining (Fig. 6A
and C). Overall S6K-pThr389 fluorescence intensity was
lower in WIP/ neurons (Fig. 6A and B), whereas
there was no difference in total S6K fluorescence inten-
sity between genotypes (Fig. 6C and D). We therefore
tested whether this reduction was greater in actin-rich
areas, where S6K-pThr389 concentrates in tumor cells
(Ip et al. 2011). We focused on growth cones and in
neuritic actin patches, the main actin-rich structures in
developing neurons.
The fluorescence intensity and the growth cone area
occupied by S6K-pThr389, S6K, or by F-actin were similar
in both genotypes (Fig. S6). However, in WIP/ neuron
growth cones, specific immunofluorescence analysis
showed preferential distribution of S6K-pThr389 in
regions not enriched in F-actin (Fig. 6E and F), in con-
trast to the more uniform S6K-pThr389 distribution in
control neuron growth cones (Fig. 6E and F).
Finally, we performed a similar quantification to ana-
lyze the distribution of S6K-pThr389 relative to F-actin
patches that spread over neuritic shafts and precede the
formation of neuritic filopodia, essential for neuritic
sprouting. In both genotypes specific immunofluorescence
analysis showed preferential distribution of S6K-pThr389
in F-actin patches compared with surrounding areas. In
contrast, the levels of S6K-pThr389 are decreased in F-
actin patches of WIP/ neurons compared to control
cells (Fig. 6G and H). These findings indicate that WIP is
a regulator of S6K-pThr389 levels and spatial distribution,
linked to kinase proximity to F-actin.
Discussion
Proper neuritogenesis shapes the integration of neurons
into functional circuits. Traditionally, research on intra-
cellular signaling has focused on axon formation as the
earliest stage of neuritogenesis. However, neuritic initia-
tion is the foremost event of neuronal morphogenesis
(Flynn 2013). Here, we show that WIP participates in the
establishment of neuritic complexity during early neuritic
initiation modulating the activity of the Abl-mTORC1-
S6K pathway. Moreover, in the absence of WIP the den-
sity of neuritic filopodia is increased and the levels of
active S6K are decreased in MF-rich area of the growth
cones. Our findings identify WIP as a key modulator of
signaling events that critically determine actin-dependent
neuritic outgrowth.
Rescue experiments (Franco et al. 2012), support the
implication of WIP in the phenotype described above.
WIP/ neurons were nucleofected with a lentiviral vec-
tor coding for control GFP or WIP-GFP. Only the expres-
sion of WIP-GFP in WIP/ neurons reversed the
average number of neuritic bifurcations per neuron at
24 h after plating (Franco et al. 2012). These data show
that the level of neuritic branching is determined by WIP.
In early neuritogenesis, WIP controls N-WASP activity by
holding N-WASP in its autoinhibited state (Franco et al.
2012). Moreover, these new data support that WIP also
regulates early neuritogenesis by modulating the activity
of Abl-mTORC1-S6K pathway in immature neurons.
WIP interacts through its proline-rich domains with pro-
teins that contain SH3-domains, involved in many in-
tracelullar signaling pathways such as Nck, Grb2, and
cortactin, and regulates other cascades including MAPK
(mitogen-activated protein kinase) or nonreceptor tyro-
sine kinases (Anton et al. 2007; Padrick and Rosen 2010).
As MAPK phosphorylation levels depend on WIP expres-
sion in murine fibroblast (Lanzardo et al. 2007), our ini-
tial analysis focused on MAPK pathways signaling. When
we analyzed WIP/ neurons, we found no significant
changes in the phosphorylation levels of these stress-med-
iated kinases (including ERK, p38 and JNK), as the minor
variations observed between genotypes for specific time
points were not consistent among independent experi-
ments (Fig. S7). These data suggest that inhibiting
mTORC1 activity in WIP/ neurons is not a side effect
of potential cell stress caused by WIP deficiency. We then
studied the PI3K-Akt-GSK3 pathway, which plays a cen-
tral role in neuronal morphogenesis (Jaworski et al. 2005;
Jaworski and Sheng 2006). In WIP/ neurons, activity of
this pathway was not statistically modified in the initial
steps of neuritic extension and axonal elongation, as
determined by Akt activation inferred from phosphoryla-
tion levels in its residues Thr308 and Ser473 and the resi-
dues Ser21/9 of its substrate GSK3. GSK3 inhibition by
Akt is necessary exclusively for the development of axons
in primary neurons (Jiang et al. 2005; Garrido et al. 2007;
Hur and Zhou 2010). Our results agree with these previ-
ous works since WIP is only involved in the development
of immature neurites and mature dendrites without
affecting axonal number or morphometry (Franco et al.
2012) (Scheme 1A).
Abl, mTORC1 and S6K are other key regulators of
neuronal morphogenesis (Moresco and Koleske 2003;
Jones et al. 2004; Jaworski and Sheng 2006). Our findings
suggest that WIP modifies the capacity of Abl family kin-
ases and of mTORC1 to phosphorylate S6K, as both
phosphorylations mediated by those proteins in the resi-
dues Ser411 and Thr389 of S6K, respectively, are reduced
in the WIP/ neurons compared to controls. WIP
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sequence contains 18 likely Abl interaction sites (http://
scansite.mit.edu/). Considering the higher abundance of
Abl as compared to Arg during brain development
(Moresco 2000) and that Abl is the only kinase that can
be related to the phosphorylation of the S6K-Ser411(Zu-
kerberg et al. 2000; Markova et al. 2010), we propose Abl
as the most probable candidate for the interaction with
WIP between the Abl family members. However, the pos-
sibility that Arg might interact with WIP cannot be
excluded. Some restrictions of our experimental model
make difficult the detection of a protein–protein associa-
tion as a direct link between WIP and Abl, mTOR, or
S6K. First, WIP and Abl are expressed at very low levels
at the studied stage of neuronal development (Perez de
Arce et al. 2010; Franco et al. 2012). Second, the interac-
tion between WIP, Abl, mTOR, or S6K might be transient
or spatially restricted to growth cones or filopodia, as
early neuritogenesis relies on highly dynamic and local-
ized molecular events (de Curtis 2007).
The Abl family plays a regulatory role in morphoge-
netic events including F-actin microspike assembly stimu-
lation (Woodring et al. 2002). Several studies support a
link between Abl and S6K: Cdk5 reaches maximum acti-
vation in response to Abl-mediated phosphorylation (Zu-
kerberg et al. 2000) and then, the Cdk5-p35 kinase
complex phosphorylates S6K at Ser411, allowing
mTORC1-mediated S6K activation in the nervous system
(Hou et al. 2007). Furthermore, Bcr-Abl activates the
mTORC1-S6K pathway independently of Akt in diverse
cell lines (Markova et al. 2010). Our results correlate well
with these data, as Abl family kinases inhibition with i-
matinib was followed by a decrease in S6K-Ser411 phos-
phorylation in WT neurons. Taken together, we propose
that Abl could mediate a yet-unidentified connection
between WIP, S6K and F-actin reorganization during
neuritogenesis (Scheme 1B).
Our results indicate that S6K activity was significantly
reduced in WIP/ neurons, as inferred from its phos-
phorylation level (S6K-Ser411 and S6K-Thr389) or deter-
mined directly from S6 phosphorylation levels. To analyze
the role of the mTORC1-S6K pathway (Laplante and
Sabatini 2009) in neuritic initiation we used the mTORC1
inhibitor rapamycin, which has been used in previous
studies mostly to define the contribution of mTORC1 to
neuronal polarization in neurons cultured for more than
3 days (Jaworski et al. 2005; Choi et al. 2008; Li et al.
2008). Nonetheless, few data exist regarding the effect of
rapamycin in early neuritogenesis. Our experiments using
inhibitors imply that the activity of both kinases is neces-
sary for proper neuron morphology in early stages of
development. We have shown that inhibiting either of the
two kinases, mTORC1 or Abl family in WT neurons gen-
erates a more complex morphology in differentiating WT
neurons – with highly branched and extended neurites –
that mimics the WIP/ phenotype. Moreover, rapamycin
treatment also induces an increase in density of neuritic
filopodia in WT neurons, suggesting that mTORC1 is
involved in the very first events associated to neurite initi-
ation and branching. With the exception of a previous
work in which mTOR and S6K activity was also inversely
correlated with the level of neuritic complexity (Guo
et al. 2011), the relationship observed between the activity
of these pathways and the level of cellular morphological
complexity differs from most of published data. These
differences may be due to the studied stage of neuron
development, as most of the published experiments have
been carried out with more mature neurons than those
studied in this work (Woodring et al. 2002; Jones et al.
2004; Jaworski et al. 2005; Choi et al. 2008). Neuritogene-
sis and axonogenesis use the same basic machinery yet in
several different ways (Flynn 2013). Thus, each stage of
neuronal maturation requires specific changes in the
activity of a given signaling pathway (Sala et al. 2000;
Sava et al. 2012). In contrast to WT neurons, imatinib or
rapamycin-treated WIP/ neurons undergo simplifica-
tion of neuritic complexity and reduction of neuritic filo-
podia density. This discrepancy might be explained by the
dose–response phenomenon termed hormesis, which is
characterized by low-dose stimulation and high-dose inhi-
bition (Calabrese et al. 2012), as our data are consistent
with the criteria established for hormetic phenomena
(Calabrese 2013). Namely: quantitative features of the
dose–response relationship, statistical significance, replica-
tion of findings, signal transduction pathway-based mech-
anism, and simulation studies using pathway inhibitors.
Hormesis may reflect the biological plasticity that arises
Figure 6. Subcellular S6K-pThr389 distribution is modified in WIP/ neurons. Representative images of hippocampal neurons from WT and WIP/
 murine embryos seeded on PLL-coated coverslips (24 h), fixed and stained with TRITC-phalloidin (F-actin, red) and Alexa488-anti-S6K-pThr389
(green) (A) or Alexa488-anti-S6K (green) (C). Scale bar, 10 lm for both. Quantification of integrated fluorescence intensity of S6K-pThr389 (B) and
anti-S6K (D) for control and WIP/ neurons. (E) Representative images of neuron growth cones obtained following the experimental design
described for Fig. 5A and C. Scale bar, 5 lm. (F) Quantification of the spatial overlap of Alexa488-anti-S6K-pThr389 signal on TRITC-phalloidin
signal in actin-sparse or -rich (dotted outline) areas. n = 12 growth cones per genotype, from two independent experiments. Student’s t-test;
**P < 0.01. (G) Representative images of neuritic F-actin patches acquired following the experimental design described for Fig. 5A and C. Scale
bar, 1 lm. (H) Quantification of the spatial overlap of Alexa488-anti-S6K-pThr389 signal on TRITC-phalloidin signal in actin-sparse (light blue
dotted outline) or -rich (white dotted outline) areas. n = 60 F-actin patches or average of either side of them per genotype, from two
independent experiments. *P < 0.05; ***P < 0.001 (Student’s t-test).
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through compensatory processes when homeostasis is
altered, as it is the case of full knockout mice. Hormetic
response pathways involve deacetylases or kinases (Matt-
son 2008), including the mTOR pathway and c-Abl (Blag-
osklonny 2011). In our system, a partial inhibition of
both pathways might be required to generate the highest
level of neuritic branching in immature neurons, whereas
a deeper or total inhibition seems to simplify the neuritic
tree.
Our findings thus indicate that WIP ultimately affects
S6K activity (Scheme 1A). S6K colocalizes with F-actin at
the leading edge of motile cells (Berven et al. 2004; Ip
et al. 2011), therefore we analyzed the distribution of this
kinase at the actin-rich leading edges of the neurites, the
growth cones. The signal intensities and areas per growth
cone of S6K-pThr389, S6K and F-actin were comparable
in WT and WIP/ neurons (Fig. S6). However, when we
examine the localization of active S6K relative to F-actin,
we found that S6K-pThr389 is mainly concentrated in F-
actin sparse regions in the absence of WIP, in contrast to
the more uniform S6K-pThr389 distribution observed in
growth cones of control neurons. In ovarian cancer cells,
phosphorylation of S6K-pThr389 promotes S6K binding to
F-actin (Ip et al. 2011). As the levels of active S6K and
F-actin are equivalent in the growth cones of both geno-
types, WIP might play a potential role as a direct or indi-
rect scaffold protein tethering S6K-pThr389 to MF in
actin-rich areas. This hypothesis could explain why S6K-
pThr389 is preferentially localized in F-actin sparse areas
in the absence of WIP, despite that the phosphorylation
on this residue promotes the binding between F-actin and
S6K.
(A)
(B)
Scheme 1. WIP controls neuritic branching through the modulation of the activity level of the Abl-mTORC1-S6K pathway. (A) Archetypical
morphology of WT and WIP/ neurons at 24 h post plating derived from our quantitative IF and biochemical data. (B) Our data permit to
postulate that in a model system of dissociated embryonic neurons, WIP determines the level of neuritic branching via the positive regulation of
the mTORC1-S6K pathway activity for the initial stages of neuronal development. The effect in two phospho-epitopes of S6K allows
hypothesizing that, in addition to mTORC1 activation (S6K-pThr389), Abl may be implicated in this initial regulation through Cdk5-p35 kinase
complex (S6K-pSer411). As the levels of active S6K and F-actin are equivalent in the growth cones of both genotypes, WIP might play a potential
role as a scaffold protein tethering S6K-pThr389 to MF in actin-rich areas. Moreover, WIP/ neurons present reduced levels of S6K-pThr389 over
the neurites and increased density of neuritic filopodia compared to controls. These data lead us to propose that WIP and active S6K may act as
negative regulators of the F-actin protrusive activity along the neuritic shaft.
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In addition to growth cones, we have also detected
actin-rich structures along the neurites. Here we show
that the density of neuritic filopodia increases while the
density of neuritic F-actin patches decreases in WIP/
neurons compared to controls. Since most of the filopo-
dia emerge from F-actin patches, but only a fraction of
patches develops to filopodia (Loudon et al. 2006), our
data suggest that the absence of WIP increases F-actin
patches conversion to neuritic filopodia along the neu-
ritic shaft. Filopodia are indispensable for neuritic initia-
tion (Dent et al. 2007; Flynn 2013). The actin-based
filopodia first protrude, then MT follow the lead of the
advancing filopodia that finally become elongating
neurites. A similar process mediates neuritic branching
(Dailey and Smith 1996; Lalli and Hall 2005; Flynn et al.
2009), which is also increased in the absence of WIP as
we describe in this study. F-actin must undergo local
de-polymerization triggered by extracellular signals to
allow cortical MF rearrangements and MT penetration
(Luo 2002; da Silva and Dotti 2002). WIP inhibits
F-actin de-polymerization (Martinez-Quiles et al. 2001),
so its absence might favor cortical cytoskeleton reorgani-
zation, required for the formation of neuritic filopodia
and neuritic branches. S6K-pThr389 might be another key
player involved in the remodeling of cortical actin, given
its localization over neuritic shafts (data presented in this
study and reported by Cammalleri et al. 2003) and its
ability to bind and stabilize F-actin (Ip et al. 2011). As
we described here, WIP/ neurons present reduced
levels of S6K-pThr389 over the neurites and in neuritic
F-actin patches compared to controls. These data lead us
to propose that the reduction of this F-actin stabilizing
protein along the neuritic shaft, and specifically in
F-actin patches, might contribute to destabilize cortical
F-actin and potentially to enhance cortical MF rearrange-
ments essential for filopodium protrusion and neuritic
branching.
In summary, this study emphasizes the importance of
WIP as an essential cytoskeletal and signaling negative
regulator in controlling events that underlie neuronal
development. Specifically, we found that WIP and the Abl
family kinases-mTORC1-S6K pathway are functionally
involved in shaping neuritic initiation, the first but least
studied stage of neuronal development. Here, we demon-
strate that WIP regulates neuritogenesis and neuritic
branching controlling Abl-mTORC1-S6K activity and the
localization of the latter relative to F-actin-rich structures.
Our study invites future research on the molecular mech-
anisms underlying these effects. Dendrite development is
intimately linked to the emergence of behavioral symp-
toms in several mental disorders such as schizophrenia
and autism. Determining the contribution of WIP to the
mechanisms that control dendrite morphogenesis and/or
maintenance will not only improve our understanding of
nervous system function, but could also help to identify
the underlying causes of some of these neurodevelopmen-
tal conditions.
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Supporting Information
Additional supporting information may be found in the
online version of this article:
Figure S1. Neuritic length per branch order is not modi-
fied in 24-h-cultured WIP/ neurons.
Figure S2. PDK1 levels are similar in WT and WIP/
neurons 24 h post plating.
Figure S3. Imatinib inhibition of Abl kinases decreases
S6K phosphorylation.
Figure S4. Rapacymin inhibition of mTOR decreases S6K
phosphorylation.
Figure S5. Rapamycin inhibition of mTOR differentially
modifies soma area and reduces axon length in WT.
Figure S6. Fluorescence intensity and area occupied by
S6K-pThr389, S6K or by F-actin are equivalent in WT and
WIP/ growth cones at 24 h after plating.
Figure S7. ERK, p38, or JNK phosphorylation levels are
similar in cultured WT and IP/ neurons in the first
48 h post plating.
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